Source: European Medicines Agency (EU) Revision Year: 2021 Publisher: Dynavax GmbH, Eichsfelder Strasse 11, D-40595 Dรผsseldorf, Germany
HEPLISAV B 20 micrograms solution for injection in pre-filled syringe.
Hepatitis B vaccine (recombinant DNA, adjuvanted).
Pharmaceutical Form |
---|
Solution for injection in pre-filled syringe. Clear to slightly opalescent, colourless to slightly yellow solution. |
One dose (0.5 ml) contains:
Hepatitis B surface antigen (HBsAg)1,2: 20 micrograms.
1 Adjuvanted with 3000 micrograms CpG 1018 adjuvant, a 22-mer oligonucleotide comprising microbial DNA-like unmethylated CpG motifs
2 Produced in yeast cells (Hansenula polymorpha) by recombinant DNA technology
For the full list of excipients, see Section 6.1.
Active Ingredient | Description | |
---|---|---|
Hepatitis B, purified antigen |
Hepatitis B vaccine induces specific humoral antibodies against hepatitis B virus surface antigen (anti-HBsAg). Hepatitis B vaccine has been recognized as the first anti-cancer vaccine because it can prevent primary liver cancer. |
List of Excipients |
---|
Sodium chloride For adjuvants, see Section 2. |
0.5 ml of solution in a pre-filled syringe (Type I glass) with tip cap (synthetic isoprene-bromobutyl rubber blend) and plunger stopper (chlorobutyl rubber). Syringes are provided without needles in packages of 5 syringes. The tip caps and stoppers of the prefilled syringes do not contain natural rubber latex.
Dynavax GmbH, Eichsfelder Strasse 11, D-40595 Dรผsseldorf, Germany
EU/1/20/1503/001
Drug | Countries | |
---|---|---|
HEPLISAV-B | Estonia, Croatia, Ireland, Lithuania, Poland, United States |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.